C07D 277/02
Not condensed with other rings
Official title: not condensed with other rings
C07D277/02 (Not condensed with other rings) appears on 6,551 US grants and 5,462 published applications in this corpus.
Search patents in C07D- Granted patents
- 6,551
- Published applications
- 5,462
- Assignees
- 2,092
- Inventors
- 16,367
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 72 | 0 |
| 1977 | 93 | 0 |
| 1978 | 94 | 0 |
| 1979 | 66 | 0 |
| 1980 | 88 | 0 |
| 1981 | 108 | 0 |
| 1982 | 80 | 0 |
| 1983 | 105 | 0 |
| 1984 | 115 | 0 |
| 1985 | 82 | 0 |
| 1986 | 84 | 0 |
| 1987 | 89 | 0 |
| 1988 | 88 | 0 |
| 1989 | 93 | 0 |
| 1990 | 112 | 0 |
| 1991 | 111 | 0 |
| 1992 | 99 | 0 |
| 1993 | 141 | 0 |
| 1994 | 103 | 0 |
| 1995 | 125 | 0 |
| 1996 | 114 | 0 |
| 1997 | 132 | 0 |
| 1998 | 129 | 0 |
| 1999 | 138 | 0 |
| 2000 | 118 | 0 |
| 2001 | 174 | 37 |
| 2002 | 157 | 178 |
| 2003 | 160 | 296 |
| 2004 | 153 | 332 |
| 2005 | 144 | 309 |
| 2006 | 168 | 261 |
| 2007 | 174 | 257 |
| 2008 | 159 | 266 |
| 2009 | 150 | 293 |
| 2010 | 205 | 323 |
| 2011 | 180 | 252 |
| 2012 | 221 | 217 |
| 2013 | 186 | 229 |
| 2014 | 243 | 261 |
| 2015 | 213 | 223 |
| 2016 | 180 | 214 |
| 2017 | 182 | 198 |
| 2018 | 145 | 175 |
| 2019 | 149 | 153 |
| 2020 | 114 | 165 |
| 2021 | 107 | 145 |
| 2022 | 97 | 170 |
| 2023 | 80 | 167 |
| 2024 | 83 | 142 |
| 2025 | 91 | 124 |
| 2026 | 57 | 75 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Polymorphs of Ponesimod15 Sep 2026US 12,735,391 B2Tapi Czech Industries S.R.O
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof18 Aug 2026US 12,709,603 B2vTv Therapeutics LLC
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Modulation of global regulatory mechanisms and biosynthetic gene clusters for simplified production of natural products1 Oct 2026US 2026/0297627 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase183US 5,409,944 AMerck Frosst Canada, Inc. · 1995